Editor's letter

Issue 152 • March 2025

Don’t miss out – sign up to our free industry-leading magazine and newsletters

Cover image: Radioactive intravenous drug using syringe. Credit: Love Employee / Getty Images

Welcome to the latest issue of Pharmaceutical Technology Focus magazine

Recent months have seen a renewed interest in radiopharmaceuticals, with a flurry of deals made by some of the biggest players in pharma. Consequently, supply chains have struggled to keep up with demand.

Despite concerns among drug developers, this month’s cover feature assesses why, in spite of some challenges, there are reasons for optimism as this latest surge in demand for the drug class unfolds.

Also in this issue, we take a look at how the Trump administration’s tariffs on China and the prospect for similar tariffs on countries like Canada and Mexico may affect the US clinical trial supply moving forward.

This month's lead interview centres on how equitable care can be ensured in the cancer space.

All this and the latest pharma industry news, comment, and analysis from GlobalData.

Ross Law, deputy editor

Go to article: Home | Radiopharmaceutical deals drive sector growth despite supply crisisGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: NiproGo to article: In DepthGo to article: Radiopharmaceutical deals drive sector growth despite supply crisisGo to article: Treating alcohol addiction: filling the medication gap Go to article: Trump’s tariffs will trickle down the clinical trial chain Go to article: The AI advantage in discovering new medicinesGo to article: EU reshapes HTAs: is the industry ready for it?Go to article: Obesity market to reach $173.5bn by 2031Go to article: People-focused cancer care demands policy supportGo to article: Endress+HauserGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Excellence Awards 2024: IFF Pharma SolutionsGo to article: Buyer's GuidesGo to article: Next issue